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Abstract
Historically the source for most organ donations were from the cadavers of deceased
donors. Over time living organ donation has become an important way to address the shortage of
organ availability. The purpose of this literature review is to explore the psychosocial effect the
organ donation process has on the living donor. The body’s physiological response to organ
donation had been well documented. However, the psychosocial effect of donation is now being
more appreciated and studies are being done to try to elucidate the factors that can influence the
living donor’s response to the transplant pro The ultimate goal of these queries is to provide
areas where clinicians can develop interventions that will enhance the post-donation experience
for the living donor. To conduct this literature review peer-reviewed, English language research
articles that were published between 2008 to the present were critiqued. In the end most living
donors had a positive experience and would not hesitate to donate their organ again; however,
there were a small minority of patients that did not fare well by psychosocial measures. These
patients many times were aware that the graft had failed in the recipient. This was the single
biggest factor in determining if the experience was positive or negative for the living donor.
Strategies, such as internet-based cognitive behavioral intervention, are being to be developed to
address the negative psychosocial outcomes that some living donors experience. Further studies
are necessary to determine additional factors that may alter the living donor’s experience and to
develop a tool-kit of interventions that can be applied as necessary to address the living donors
specific needs.
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Introduction
In the United States (US), 34,770 solid organ transplants were performed in 2017 (U.S.
Department of Health and Human Services, 2018). The number of solid organ transplants
performed in the US increases each year causing an ever-growing number of people with endstage organ failure to be placed on waiting lists until a matched donor organ is available. As of
2018, there were 114,000 people awaiting a solid organ transplant (U.S. Department of Health
and Human Services, 2018). Renal transplants comprise approximately 56% of the solid organ
transplants performed in the US in 2017 while liver transplants account for approximately 23%
of the solid organ transplants during that year (U.S. Department of Health and Human Services,
2018). Regretfully, many individuals with end-stage organ failure placed on waiting lists for
solid organ transplant will not receive a transplant in time. As many as 20 people die each day in
the US waiting for a compatible organ for transplant (U.S. Department of Health and Human
Services, 2018). Unlike other solid organ transplants, organs for kidney and liver transplant can
come from healthy living donors as well as recently deceased donors. In the case of liver and
kidney transplantation, organs volunteered from living donors can greatly expand the availability
of viable organs for transplant. In some instances, complications and side effects related to organ
donation can arise that adversely affect the donor. In the proceeding fifty years much of the focus
has been placed on long-term complications the recipient of an organ endures. However, there is
a paucity of research that explores the long-term consequences of organ donation experienced by
the living transplant donor.
There are several unique burdens a person donating an organ can experience during the
years following surgical excision of a healthy organ. Organ donors may potentially have to take
leave from work due to unforeseen complications arising from donation, and the donor can then
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have problems paying their monthly bills. In addition, donors may be denied health insurance
and life insurance following donation, which causes long-term financial difficulties. Besides the
financial burden that donors may incur due to time off work and future insurability issues, donors
may experience emotional, substance abuse, or other negative psychosocial burdens. While most
living organ donors do not experience any ill effects from donating their organs, up to 10% of
living kidney donors experience negative psychosocial outcomes (Jacobs, Gross, Messersmith,
Hong, Gillespie, Hill-Callahan, Taler, Jowsey, Beebe, Matas, Odim, & Ibrahim, 2015). Some
indicators such as underlying psychological distress and substance abuse problems are known
before undergoing donation and can increase the likelihood of the donor experiencing negative
psychosocial outcomes. On the other hand, lack of support and graft failure are important
indicators that can lead to negative psychosocial outcomes but are not apparent until after the
procedure. Jacobs and colleagues reported that up to 38% of kidney donors feel that they do not
receive support even from hospital staff following organ donation (Jacobs, et al., 2015).
However, graft failure was the greatest predictor of negative psychosocial outcome in posttransplant donors (Jacobs, et al., 2015). Despite recognition that the negative psychosocial
outcomes can be problematic for a subset of organ donors, little has been proposed in the way of
interventions that may improve the donor’s long-term experience.
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Problem
Living donor organ transplantation provides organs to individuals with organ failure that
would otherwise remain on waiting lists due to the lack of availability of solid organs suitable for
transplantation. However, since the inception of living organ donor transplantation, little
attention has been paid to the long-term consequences the organ donor has to endure following
the procedure. Evaluation of transplanted organs has mainly focused on the physiologic and
psychologic long-term outcomes in organ recipients, although more recently, problems
experienced by living organ donors is gaining attention.
The negative financial and psychosocial effects organ donation has on the living donor
has become more apparent. The single biggest predictor of the donor experiencing a negative
psychosocial outcome is related to whether the graft fails after being implanted into the recipient.
Identifying interventions aimed at alleviating the negative psychosocial effects of transplantation
for donors would be beneficial in improving outcomes. Given that donors whose recipients had a
graft failure are at the highest risk of developing negative psychosocial consequences,
identifying the subset of living organ donors with recipients that have grafts failure or rejection
might be an effective way of improving their transplant experience.
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Purpose
The purpose of this literature review is to analyze the negative psychosocial effects that
organ donors experience after donation and to understand which donors are most at risk for
suffering negative experiences related to organ donation. It has been suggested that living kidney
donors experience mood disorders, fear of future organ failure, body image issues, and life
dissatisfaction more frequently than healthy controls (Rodrigue, Schold, Morrissey, Whiting,
Vella, Kayler, Katz, Jones, Kaplan, Fleishman, Pavlakis, & Mandelbrot, 2017). Exploring
effective interventions aimed at identifying possible complications of organ donation pre- and
post-transplant in the recipient and in the living donor could be useful in ensuring the best
possible psychologic and physiologic outcomes are experienced by the living donor.
The United Network for Organ Sharing (UNOS) has identified areas that can be assessed
as part of a psychosocial evaluation prior to donation. The areas identified by UNOS include
motivation to donate, social support, health behaviors, psychosocial history, psychiatric history,
donor knowledge and understanding of the risks, and family history as wells as financial history
and legal preparedness (Rudow, Swartz, Phillips, Hollenberger, Schmick, & Steel, 2015).
Another pre-donation screening tool developed is the Ethical, Legal, and Psychosocial Aspects
of Organ Transplantation (EPAT) (Massey, Timmerman, Ismail, Duerinckx, Lopes, Maple,
Mega, Papachristou, & Dobbels, 2017). Screening tools can assist the transplant team in the
identification of living donors at risk for poor psychosocial and physiologic outcomes after
donation and can raise awareness of the implications organ donation has on donor health status.
Understanding the effects of organ donation on the living donor will aid in caring for
donors post-transplant. Many individuals donating an organ will have positive experiences
before and after donation; however, organ donation has both physiologic and psychosocial
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effects that can vary between individual experiences. Interventions can be developed to prevent
or lessen the impact of the physiologic and psychosocial effects on the donor. The information
synthesized from this literature review is expected to address physiologic and psychosocial
experiences of living organ donors and to explore interventions aimed at reducing the negative
aspects of organ donation pre- and post-donation.
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Method
A review of the literature will be conducted to examine the physiologic and psychosocial
effects of organ transplantation on living donors from the following online databases:
Cumulative Index to Nursing and Allied Health Literature (CINAHL), Medical Literature OnLine (MEDLINE), Educational Resource Information Center (ERIC), and Psychological
Information database (PsycINFO) (Appendix A, Figure 1). Searches used a combination of the
following terms: ‘organ transplant*’, ‘living donor*’, ‘physiologic*’, and ‘psychosocial*’.
Articles included in the review will be published from 2008-2019, in the English language from
peer-reviewed journals. Articles will be reviewed to ensure relevance to the topic. Inclusion
criteria will consist of 1) focus on physiologic and psychosocial health status of living donor preand post-donation, 2) experience of donation from the donor’s perspective, and 3) interventions
aimed at minimizing negative experiences from the donor’s point of view. Articles that focus on
the recipient experience in living donor organ transplantation will be excluded.
No relevant articles were identified when all four search terms were used. When,
physiologic* was excluded from the search, 258 articles were found (Appendix A, Figure 1). 57
articles were evaluated and individually critiqued. Only one article met the inclusion criteria by
specifically addressing both the psychosocial and physiological effects of organ donation.
Another 17 articles were identified that pertained to the psychosocial effects of organ donation
on the living donor. Three articles were identified that were outside the date range of the search
but were included to provide historical context for studies pertaining to living liver donation.
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Background
Organ failure
Organ systems in the human body have specialized tasks to perform functions that
maintain homeostasis. In certain disease conditions, pathological changes can occur in the body’s
organs and impair their ability to properly function. Overtime pathological changes can cause the
organ to become permanently damaged, losing the ability to function and perform its
physiological role. When this happens, it is difficult for the body to compensate for the loss of
the organ due to tissue specialization innate to each organ and the biologic inability to regrow a
new organ. Ultimately the failure of an organ can lead to death. Solid organ transplantation is a
procedure that is performed when one or more organs have failed in attempt to restore organ
function. The procedure requires an intricate process that involves the screening patients and
donors, procurement of an organ, transporting the organ between institutions, and the
implantation into the patient with the failing organ. When the first kidney transplant was
performed in 1954 between two living identical twins, death would have been a common
sequelae from organ failure (Keller, 2015). Over the 6 decades since solid organ transplantation
has been performed great advances have been made in the types of organs that can be
transplanted and the survivability of the procedure. Kidney, liver, heart, and lung transplantation
are some of the most common solid organ transplants performed today (Keller, 2015).
Postsurgical management following transplantation has been an important advancement that has
enabled transplanted organs to function for extended periods of time. Early on survival rates
were low, but the introduction of immunosuppressant therapy opened the door to improved
treatment for organ transplant patients.
Living Organ Donation
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Historically, transplanted organs were obtained from a deceased donor. Due to the nature
of procuring organs from deceased donors, the need for organs greatly outpaced the availability
of the organs. Most patients who received organ transplants obtained their organs from deceased
donors. Lack of donations and the fact that all organs from deceased donors are not useable in
transplantation greatly reduces the number of patients who can receive a new organ. While a
majority of the organs utilized in transplantation still come from deceased donors, approximately
4 out of 10 are obtained from live donors (U.S. Department of Health and Human Services,
2018). Being able to remove a whole or part of an organ from a living donor and then implanting
it into a recipient has greatly expanded the number of organs, such as the kidney or liver, that are
available for transplantation. However, the ability to remove an organ or a part of one from a
living donor and transfer the organ to a recipient presents a unique set of ethical and medical
issues for all involved.
Medical Management
Advancements in post-surgical management of transplant recipients has increased their
survival rate. Immunosuppressant therapy has assisted in reducing the incidence of organ
rejection in transplant recipients. Cyclosporine, which was first used in the early 1980’s, was a
mammoth advance that helps prevent the recipient from rejecting the donor organ (Keller, 2015).
Another important area in the management of individuals with transplanted organs has been in
preventing infections due to immunosuppression. However, much less research has been done to
characterize the long-term effects of organ transplantation on the living donor. While living
donors do not have to worry about rejecting their remaining organ or infections like recipients,
other complications often arise that can greatly affect the living donor’s quality of life. It is
possible for the donor’s remaining organ to fail, which would then necessitate them receiving an
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organ transplant. Recognizing that organ donation is not a benign process and can have
ramifications on the living donor’s life is an important advance in the transplant process.
Psychosocial Effect in Transplantation
Historically much of the attention has focused on the effects that organ transplantation
has on the recipient. Besides having to consider organ rejection in recipients post-transplant,
recipients are also at risk for developing negative psychosocial outcomes following the
procedure. Depression, anxiety, aggression, and hopelessness are a few of the reported negative
psychosocial changes that have been reported in people with chronic illnesses (Schulz &
Kroencke, 2015). Addressing psychosocial issues has long-term implications for the health of the
transplant recipient. For example, depression in a transplant recipient can lead to lack of
compliance with their immunosuppressant regimen and a decrease in their quality of life
(Heinrich & Marcangelo, 2009). This is important because without adhering to the
immunosuppressant regimen, the recipient could possible suffer organ rejection. After
undergoing surgical implant of a donor organ, the potential for adverse psychosocial effects is
greatest the first year after transplant. There are also financial pressures on living organ donors,
just as there are for people with chronic illnesses, due to missing work following the procedure
and due to the recovery period. One psychosocial dimension that is different for living organ
donors pertains to whether the transplantation was successful or not. Graft success or failure is an
important predictor of psychosocial outcomes experienced by the living organ donor with graft
failure leading to potentially negative outcomes.
In the current body of literature, the effects of organ transplantation in living
organ donors is not as well delineated. In living tissue donation, kidneys are the most common
organ that is harvested and transplanted. The transplantation of livers from living donors is less
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common but still represents a significant number of procedures. Recently, the risks posed by
donating organs has been a focus of concern. Beyond having a potential effect on the donor’s
health, other factors precipitated by organ donation can affect the donor’s quality of life. The
adverse effects that occur to organ donors can determine how they perceive the procedure. Most
donors donate their organs willingly to benefit those in need. This altruistic act normally has a
beneficial psychological effect on the donor. However, a minority of organ living organ donors
have a negative outcome from the donation process and this can greatly affect the donor’s
perception of the procedure. When the living donor experiences either a negative health or
psychosocial outcome, the living donor is more likely to regret the decision to donate their organ
in the first place. Understanding which living donors are at risk for developing adverse effects
from donating may allow health care providers to intervene, which will ultimately make for a
more positive experience for the living organ donor.
Organ donation can have multifactorial effects on the living donor’s health status, as well
as on the individual’s mental health well-being. In the case of kidney transplantation, the living
donor undergoes surgical resection and harvest of a healthy kidney to a recipient. The living
donor can successfully maintain physiologic homeostasis with one functional kidney, which is
why the procedure is feasible. To compensate the remaining kidney might hypertrophy. The
increase in size is indicative of the increased functional role even though the total capacity has
been reduced by removal of one of the organs. Once the living donor has donated their kidney,
the donor is at risk if their remaining kidney were to fail. The living donor in this situation would
require a kidney transplant. Even if the living donor’s remaining kidney does not completely fail,
it is possible that their kidney function may still decline. Meyer and colleagues reported that 26.7
percent of the living kidney donors had a low estimated glomerular filtration rate (eGFR)
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(Meyer, Hartmann, Mjøen, & Andersen, 2017). A living donor was defined as having a low
eGFR if it was less than 60 mL/min/1.73 m2. In addition, Meyer and colleagues reported that
33.2 percent of the living donors in the cohort reported having hypertension following organ
donation (Meyer, et al., 2017). In the study hypertension was defined as having a blood pressure
greater than 140/90. One of the kidney’s functions is in regulating blood pressure. The alterations
caused by donating a kidney might explain why living donors experience an increase in blood
pressure.
The psychosocial effects of transplantation on the living donor are less understood. Since
only a minority of living donors experience a negative psychosocial outcome, it is imperative to
understand which donors are more likely to experience the complications. Factors such as age,
relationship status, social support, financial status, and coping style have been looked at in
relation to the development of negative psychosocial outcomes in living donors. Age has been
identified as a predictor of negative psychosocial wellbeing after organ donation in living donors.
Younger kidney donors who were not married are more likely to exhibit negative psychosocial
effects post-donation. The same trend has been observed in living liver donors. Being 40 to 50
years old was associated with a more positive effect on the donation experience (Dew,
DiMartini, Ladner, Simpson, Pomfret, Gillespie, Merion, Zee, Smith, Holtzman, Sherker,
Weinrieb, Fisher, Emond, Friese, Burton, & Butt, 2016). Also, the financial burden resulting
from organ donation can be substantial. The living donor may miss work, which can lead to a
decrease in wages. In addition, the recovery period can sometimes be longer than expected. The
longer it takes to recover can strain finances. Another financial hardship can be placed on the
donor due to the inability to get health and life insurance years after the donation. Financial and
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social support can affect the level of stress the living organ donor experiences. The living
donor’s ability to cope with these stresses will affect their perception of the donation process.
Further, living organ donors have many of the same psychosocial changes experienced in
the organ donor recipients. Living organ donors can have depression and anxiety due to changes
in their health status and fear regarding what happens if their remaining organ fails. Living organ
donor may be frustrated due to the perception that once they have donated their organ they are an
afterthought and do not receive as much follow-up by the healthcare team following the
procedure. There are also financial pressures on living organ donors, just as there are for people
with chronic illnesses, due to missing work following the procedure and due to the recovery
period. One psychosocial dimension that is different for living organ donors pertains to whether
the transplantation was successful or not. Graft success or failure is an important predictor of
psychosocial outcomes experienced by the living organ donor with graft failure leading to
potentially negative outcomes.
Graft failure in organ transplantation has serious implications for the recipient’s ability to
survive short of receiving another organ donation. While this is imminently more stressful for the
organ recipient due to the life and death issues presented by the situation, it is also
understandable that the person who just donated an organ could also be affected by this adverse
outcome. Graft failure has been shown to be one of the few causes for living donors to have
regrets in undergoing the organ transplantation process (Meyer, Wahl, BjØrk, WislØff, Harmann,
& Andersen, 2016). There are many reasons why graft rejection could lead to regrets the donor
experiences. The donor could resent the time and financial burden that they went through if the
graft rejects. Graft failure could be particularly difficult for the living donor if the recipient was a
close relative. The donor could experience a feeling of guilt due to the fact that the recipient did
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not survive. Understanding the guilt that living organ donors experience and developing nursing
interventions to alleviate this negative psychosocial effect will be invaluable for improving the
donor’s experience following the transplantation procedure.
Education
Interventions used to lessen the impact of transplant complications affecting the living
donor would be useful to alleviate negative psychosocial effects of the transplant process on the
living donor. Psychosocial causes of distress that effect the living donor can be difficult to target.
Some examples have been suggested in the literature for interventions to prevent poor
psychosocial outcomes. One example is of an internet-based cognitive-behavioral intervention
(ICBT). In this pilot study the health-related quality of life, anxiety, and depression were
observed before and after the intervention to see if the ICBT was effective at alleviating
problems associated with organ donation (Wirken, van Middendorp, Hooghof, Bremer, Hopman,
van der Pant, Hoitsma, Hillbrands, & Evers, 2018). The ICBT had extensive donation-related
treatment modules, assignments, and psychoeducation. In the pilot study, most participants
reported benefits on health and psychological health-related quality of life measures, depression
measures, and in reports of fatigue. Further studies are warranted because the scores are based
off the responses of eight living donors. This provides a starting point to develop this and other
methods to prevent living donors from developing negative psychosocial outcomes that
negatively affect their transplant experience.
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Results
Twenty-one studies were identified related to the psychosocial effect organ donation has
on the living organ donor. The studies were included in the literature review. Included in the
articles were two sentinel studies, one of which was a pilot study in the discipline, from 2001 and
2002. Twenty studies had been published since 2008. All the studies were cohort studies. All the
studies used various questionnaires to measure the living donors’ quality of life. Five of the
studies involved qualitative interviews of the living donors following the transplant procedure.
Psychosocial Outcomes in Living Donors Post-Donation
The literature review identified two major groups of living organ donors. The majority of
living organ donation involves transplantation of the kidney; however, there are a significant
number of liver transplants involving living organ donors. The studies synthesized in the
literature search identified certain factors that can negatively affect the psychosocial outcomes
kidney and liver donors experience.
Psychosocial Outcomes in Living Kidney Donors
Ten studies were identified that explored the psychosocial effect of organ donation in
living kidney donors.
The health-related quality of life (HRQoL) questionnaire was examined in living kidney
donors (LKD) for a small cohort study, which involved the donors responding to the Short Form36 (SF-36), Giessen Subjective Complaint List (GBB-24), and the Zerssen’s Mood Scale (Bf-S)
questionnaires (Maglakelidze, Pantsulaia, Managadze, & Chkhotua, 2011). In the eight domains
of the SF-36, social function (p=0.0001), bodily pain (p=0.0357), and vitality (p=0.0478) were
domains the living kidney donors scored higher and more positive ratings than the control
patients or renal tumor patients who had undergone nephrectomies (Maglakelidze et al., 2011).
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In addition, the living kidney donors (LKD) scored higher in the GBB-24, and the only domain
in which the difference in scores was statistically significant was in the gastric complaints
domain (p=0.008) (Maglakelidze et al., 2011). In the Bf-S questionnaire, the living donors scored
higher than both the control and renal tumor patients (p=0.0007 versus controls and p < 0.0001
versus patients) (Maglakelidze et al., 2011). This study indicated that LKDs fared well following
organ donation by the measures of HRQoL included in the study.
Another study explored the effect organ donation had on psychosocial outcomes in
LKDs. In the study, various questionnaires were employed to measure the effect organ donation
had on the LKDs psychosocial outcomes (Maple, Chilcot, Weinman, & Mamode, 2017). The
Short Form-12 (SF-12) was utilized to measure the LKDs physical HRQoL (Maple et al., 2017).
The LKDs were found to have a significantly lower SF-12 score 3 months following donation (p
< 0.05); however, the SF-12 score at 12 months following donation was lower than the predonation score but not significantly lower (Maple et al., 2017). This study also found that by all
measures LKDs had very little change in their HRQoL by 12 months after kidney donation.
In another cohort study, the investigators were interested in determining the long-term
effects on mood in organ donors following kidney donation. The investigators utilized the Patient
Health Questionnaire (PHQ-9) depression screening instrument, the Life Orientation TestRevised, and the 36-Item Short Form Health Survey to screen LKDs following donation
(Jowsey, Jacobs, Gross, Hong, Messersmith, Gillespie, Beebe, Kew, Matas, Yusen, HillCallahan, Odim, Taler, & the RELIVE Study Group, 2014). The study found the biggest
predictors of the living organ donor suffering from symptoms of depression following kidney
donation consisted of being a race other than white (p=0.020), being younger when they donated
their kidney (p=0.002), having a longer recovery time following donation (p=0.0009), having a
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large financial burden (p=0.013), and feeling obligated to donate the kidney (p=0.003) (Jowsey
et al., 2014). The study identified factors that could indicate the living donor was more likely to
develop depression following organ donation even though the overall prevalence of depression
was similar between LKD and the controls.
Other psychosocial outcomes evaluated following organ donation included mood, body
image, fear of kidney failure, and decisional stability. One study used the Profile of Mood States
(POMS) to assess anxiety, depression, and mood, the 5-Item Fear of Kidney Failure
questionnaire, 10-Item Body Image Scale (BIS), and 5-Item Satisfaction with Life Scale (SWLS)
to measure the psychosocial outcomes in LKDs (Rodrigue et al., 2017). The outcomes measured
in this study yielded similar results for LKDs and healthy controls (HC). When looking for
predictors of psychosocial outcomes following donation, older age was associated with less
chance of developing a mood disorder post-donation (p=0.001) and having a mood disorder predonation was more likely to be associated with a mood disorder following donation (p=0.01)
(Rodrigue et al., 2017). The predictors of fear of kidney failure were marital status with being
married associated with less change of developing the fear (p=0.004) and pre-donation fear of
kidney failure increasing the chances of developing the fear post-donation (p < 0.001) (Rodrigue
et al., 2017). Pre-donation body image issues and feeling pressured to donate were predictors of
having body image issues following donation (p=0.002 and p=0.02, respectively) (Rodrigue et
al., 2017). Being white was associated with a decreased chance of developing life dissatisfaction
while pre-donation life dissatisfaction was associated with an increased chance of developing life
dissatisfaction following donation (p=0.003 and p <0.001, respectively) (Rodrigue et al., 2017).
While the LKDs and HCs had comparable psychosocial outcomes, several predictors of negative
outcomes for LKDs were identified in this study.
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The factors that have negative and positive effects on LKDs along with the HRQoL were
explored in a randomized, cohort study (Hsieh, Chien, Liu, Wang, Lin, & Chiang, 2017)
following organ donation. In this study women demonstrated a higher positive psychosocial
effect than men (p < 0.05) (Hsieh et al., 2017) following the donation and transplant experience.
Also, lack of having a chronic disease was associated with having a positive effect on
psychosocial perceptions of the donation experience (Hsieh et al., 2017). The psychosocial
ratings were more favorable following organ donation if the person perceived themselves as
having greater physical health prior to the organ donation (p < 0.01) (Hsieh et al., 2017). When
the psychosocial effects of organ donation were rated as higher by the donor, the LKDs generally
had higher HRQoL scores (p < 0.05) (Hsieh et al., 2017). This study indicated that LKDs rating
their donation experience as positive with fewer negative effects had higher HRQoL scores.
To predict mental health following donation in LKDs, several psychological factors were
explored to determine their effect on mental health. In one prospective cohort study
(Timmerman, Timman, Laging, Zuidema, Beck, Ijzermans, Busschbach, Weimar, & Massey,
2016), the authors reported that being young (p=0.002) and having a deficiency in social support
indicated and increased risk for negative psychological symptoms (Timmerman et al., 2016).
Also, increased amounts of stress led to a decrease in overall well-being (p < 0.001)
(Timmerman et al., 2016). Providers that recognize potential predictors of negative psychosocial
outcomes in LKD can improve the organ donation experience by optimizing interventions aimed
at decreasing stress in the donor and by surrounding the donor with supportive individuals.
Previously, Timmerman, Laging, Westerhof, Timman, Zuidema, Beck, Ijzermans, Betjes,
Busschbach, Weimar, & Massey (2015) suggested there was no difference between the mental
health outcomes for LKDs and HCs. The authors reported no change in psychological complaints
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(p=0.20) or in well-being (p=0.10) for LKDs following organ donation (Timmerman et al.,
2015). There was also no difference detected between the LKDs and HCs in regards to changes
in psychological complaints and in well-being (p= 0.48 and p=0.85, respectively) (Timmerman
et al., 2015). Ultimately this study suggests there are no discernible differences between LKDs
and HCs in mental health outcomes.
Another group looked at the prevalence of anxiety, depression, and regret of donation in
LKDs following donation. In this cohort study, the rates of anxiety, depression, and regret of
donation in LKDs was 5.5%, 4.2%, and 2.1%, respectively (Holscher, Leanza, Thomas,
Waldram, Haugen, Jackson, Bae, Massie, & Segev, 2018). The chances of a positive screening
for depression were higher if the LKD screened positive for anxiety (p < 0.001) (Holscher et al.,
2018). There was also an increased chance of having a positive depression screen if the recipient
of the kidney lost the graft (p < 0.001) (Holscher et al., 2018). The LKD was more likely to
regret the decision to donate the kidney if the LKD had a positive anxiety screen (p < 0.0001)
(Holscher et al., 2018). These factors were the only ones that were found in this study to be
predictors associated with anxiety, depression, or regret of donation.
Meyer, Wahl, Bjørk, Wisløff, Hartmann, & Andersen (2016) reported on quality of life
(QoL) measures eight to twelve years following the living donor’s kidney donation. Most of the
donors had high QoL scores. The only significant findings were that women had higher fatigue
score than men (Meyer et al., 2016). Women scored significantly higher than men in general
fatigue (p=0.01), physical fatigue (p=0.01), reduced motivation (p=0.04), and mental fatigue
(p=0.03) (Meyer et al., 2016). Gender may be a factor that clinicians may look at in LKDs to
ensure that female donors are not adversely affected by fatigue following donation.
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Like other studies, graft failure was identified as a factor in poor psychological outcomes
of LKDs (Jacobs, Gross, Messersmith, Hong, Gillespie, Hill-Callahan, Taler, Jowsey, Beebe,
Matas, Odim, Ibrahim, & the RELIVE Study Group, 2015). The study suggested one in ten
LKDs experienced a negative psychosocial or financial consequence following donation (Jacobs
et al., 2015). The only predictor of a negative psychosocial outcome statistically significant was
if the recipient’s kidney was no longer functioning (p < 0.001) (Jacobs et al., 2015). This is
consistent with the findings of similar cohorts of living organ donors. Graft failure has been
reported to have negative consequences on the LKDs psychosocial outcomes (Holscher et al.,
2018).
Psychosocial Outcomes in Living Liver Donors
Ten studies were identified that addressed the psychosocial outcomes in living liver
donors (LLD). Three of the cohort studies did not meet the inclusion criteria because they were
published before 2008, when there was a sharp increase and better outcomes in living organ
donation due to advanced drug therapies and surgical techniques but were included to give
context to the topic.
Walter, Bronner, Pascher, Steinmüller, Neuhaus, Klapp, & Danzer (2002) looked at the
psychosocial outcomes of LLDs at six months following the transplant procedure. Overall the
participants in the study had a higher global quality of life 6 months after the procedure
(p=0.044) (Walter et al., 2002). However, 26% of the LLDs also had high values for tiredness (p
< 0.0012) and fatigue (p < 0.0012). Ultimately most of the LLDs in the study had a good QoL
following donation, and the procedure could be done without the ethical dilemma of doing harm
to the donor.
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Another early article described the QoL of LLD before and after liver donation. The
LLDs were assessed using the WHOQoL questionnaire (Walter, Dammann, Papachristou,
Neuhaus, Danzer, & Klapp, 2003). Before donating the LLDs scored higher on the WHOQoL
questionnaire than the general population (p < 0.05) (Walter eta l., 2003). At six months, the
LLDs were re-assessed with the WHOQoL and the LLDs score significantly lower on physical
health (p < 0.05) and living conditions (p < 0.05) than before they donated their livers (Walter et
al., 2003). This study suggested the LLD’s, had a positive psychosocial outcome after partial
organ donation following transplantation to the recipient.
In the final early cohort study, the authors looked at the QoL that LLDs experienced
following transplant. The LLDs scored similar to HCs on the SF-36, which has been a validated
questionnaire to assess QoL. The only domains that the LLDs differed from the HCs were
physical function, social function, and mental health (p < 0.05) (Trotter, Talamantes, McClure,
Wachs, Bak, Trouillot, Kugelmas, Everson, & Kam, 2001). Ultimately, the some LLDs reported
body image issues, mild ongoing symptoms such as abdominal discomfort, significant out of
pocket expenses; however, all the LLDs stated that they would donate a portion of their livers
again if given the chance (Trotter et al., 2001). This was an early study that demonstrated the
lack of harmful effect for people donating a section of their liver to another.
DuBay, Holtzman, Adcock, Abbey, Greenwood, Macleod, Kashfi, Jacob, Renner, Grant,
Levy, & Therapondos (2009) looked at the QoL living donors experienced and looked at
predictors to those outcomes. The physical composite score as measured by the responses of
LLDs on the SF-36 demonstrated a higher physical composite score (p < 0.001) (DuBay et al.,
2009). Physical functioning (p < 0.001), role interference (p < 0.05), bodily pain (p < 0.001),
general health (p < 0.001), and vitality (p < 0.05) were all domains that the LLDs scored better
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than the average Canadian on (DuBay et al., 2009). While LLDs reported mental health scores
on the SF-36 similar to the average Canadian, there were several predictors , such as age
(p=0.023), presence of a psychiatric diagnosis (p=0.007), degree attained (p=0.001), and predonation concerns about donation all (p=0.029) that were all predictors of mental health changes
seen following liver donation (DuBay et al., 2009). This study identified some predictors that
could cause changes in a LLDs mental health outcomes following organ donation.
In a multicenter cohort study, the authors identified several factors that affect the
psychological outcomes in LLDs. Butt, Dew, Liu, Simpson, Smith, Zee, Gillespie, Abbey,
Ladner, Weinrieb, Fisher, Hafliger, Terrault, Burton, Sherker, & DiMartini (2017) identified
factors that affect the Simmons better person score were time since donation (p < 0.001), being a
first degree relative versus unrelated (p=0.012), female gender (p=0.008), recipient death (p <
0.001), ambivalence (p=0.005), and motivation to donate (p < 0.001) (Butt et al., 2017). The
predictor that was more likely to be associated with a negative donation experience was the death
of the recipient. Up to 22% of the LLDs felt responsible when the recipient died following the
transplant (Butt et al., 2017). This study reiterated the fact that the recipient’s outcome can have
a great effect on the donor’s experience.
A cohort study conducted in Japan, compared the psychological outcomes of recipient
and donors three to five years following living donor liver transplants. In this study, the social
QoL (p= 0.026) and total QoL (p=0.005) were lower after the donation procedure (Noma,
Hayashi, Uehara, Uemoto, & Murai, 2011). LLDs also reported fewer anxiety symptoms
following transplantation (Noma, et al., 2011). The study identified social support as a predictor
of QoL following donation. Those living donors with less familial support had a greater chance
of worse psychosocial outcome following organ donation. Knowing predictors of these outcomes
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could allowed clinicians to target this patient population to prevent a negative experience
following donation.
In a long-term study, Ladner, Dew, Forney, Gillespie, Brown, Merion, Freise, Hayashi,
Hong, Ashworth, Berg, Burton, Shaked, & Butt (2015) followed LLDs for up to 11 years
following transplant. The best predictor of a negative score on the SF-36 was if the recipient had
died within 2 years of receiving the kidney transplant (Ladner et al., 2015). One factor that was
identified as a protective factor was education. LLDs that had a bachelor’s degree generally
reported a higher PCS score on the SF-36 (Ladner et al., 2015). Even though most LLDs have a
positive experience following organ donation, and higher education was identified as a
significant to improved quality of life following organ donation. This can assist clinicians with
determining which LLDs need further education and reinforcement of the psychosocial
expectations following donation to lessen the chance of adversely affecting the LLD’s HRQoL.
A long-term cohort study was conducted to evaluate the prevalence of adverse
psychosocial outcomes in LLDs (Dew, Butt, Liu, Simpson, Zee, Ladner, Holtzman, Smith,
Pomfret, Merion, Gillespie, Sherker, Fisher, Olthoff, Burton, Terrault, Fox, & DiMartini, 2018).
The authors in this study found that LLDs were more likely to have anxiety and alcohol abuse
disorder (Dew et al., 2018). Other factors, such as length of hospital stay, female gender, higher
body mass index (BMI), fear of health related effects, and out-of-pocket expenses were
associated with a worse QoL (Dew et al., 2018). Anxiety and substance abuse disorders can have
a negative impact on the QoL that a LLD has. Screening prior to organ donation for individuals
at risk of developing substance abuse problems in a LLD population would be beneficial.
Previously, Dew, DiMartini, Ladner, Simpson, Pomfret, Gillespie, Merion, Zee, Smith,
Holtzman, Sherker, Weinrieb, Fisher, Emond, Freise, Burton, and Butt (2016) found several
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factors that led to lower HRQoL. These factors included male gender (p<0.001) and being nonHispanic white (p<0.001) (Dew et al., 2016). The authors also identified a factor that had a
positive effect on HRQoL, which was being between 40 to 50 years old (p=0.008) (Dew et al.,
2016). Additionally, the MCS scores were poorer in those donors that had extended
hospitalizations following donation (p=0.009) indicating a decrease in the HRQoL (Dew et al.,
2016). While age can be a protective factor, other predictive factors such as financial costs,
extended hospitalization, race, and gender might be used to identify donors that require followup care and long-term surveillance.
Kimura, Onishi, Sunada, Kishi, Suzuki, Tsuboi, Yamaguchi, Imai, Kamei, Fujisiro,
Okada, Ishigami, Kiuchi, & Ozaki (2015) evaluated the impact psychiatric conditions had on
LLDs. The authors identified 6 individuals who had not had a psychiatric issue before donation
and subsequently developed a psychiatric disorder following organ donation. The 6 individuals
represent 4.2% of the total number of LLDs (n=142) screened for participation in the study
(Kimura et al., 2015). The LLDs with a mental health disorder and were treated for the disorders,
were evaluated before and after the organ donation process. Half of the LLDs were able to stop
drug therapy during the donation process while the other half required therapy over an extended
time frame (Kimura et al., 2015). The low prevalence of mental health disorders in individuals
that donate organs can make it difficult to draw conclusions from a small cohort of living organ
donors.
The Relationship Between Physiological and Psychosocial Outcomes in LKD
There was one study that met the inclusion criteria and addressed both the physiological
functioning of the kidney following donation and the psychosocial impact of donation.
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The long-term effects of kidney donation on the living donor are not well elucidated
particularly when trying to determine whether physiological functions affect psychosocial
outcomes. Meyer, Hartmann, Mjøen, & Andersen (2017) attempted to correlate physiologic
functioning with QoL in LKDs. There were no significant associations that could be drawn
between clinical variables, such as blood pressure (BP), creatinine, estimated glomerular
filtration rate (eGFR), hemoglobin, or cholesterol panels, and QoL scores on the SF-36 (Meyer et
al., 2017). The only correlations that could be discerned were between gender and general
fatigue (p < 0.05) and between BMI and physical fatigue (p < 0.01) (Meyer et al., 2107). This
small-scale study failed to really find a correlation between physiological function 10 years
following kidney donation and the LKDs QoL.
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Discussion
The studies included in this literature review can provide insight into the psychosocial
effects that organ donation has on the living donor; however, other factors concerning the
donation process and outcomes in the transplant recipient that may be important in the living
donor’s experience following donation have yet to be identified. The main factor identified in
several of the studies was that graft failure and the resultant death of the recipient led to feelings
of guilt and negatively affected the psychosocial outcomes experienced by the living donors.
Various studies also identified predictors that indicated whether the living donors experienced
psychosocial sequelae from donating their organs.
Psychosocial Outcomes Experienced by Living Donors
Most LKDs and LLDs experienced no adverse effects from donating their organs to
another person. Some living donors even demonstrated higher measures of psychosocial
functioning after they had donated their organ. There were a number of LKDs that experienced
mood disturbances following donation of their kidney. Up to 16% of LKDs were found to have
new-onset mood disturbances following kidney donation (Rodrigue et al., 2017). The studies by
in large used questionnaire to measure the living donors’ QoL. Several of the studies also
employed interviews to ascertain the donors’ feelings about the transplant experience.
Most of the studies found that living donors had no negative consequences following the
transplant procedure (Ladner et al., 2015; Maglakelidze et al., 2011; Maple et al., 2017; Meyer et
al., 2017; Timmermann et al., 2015). There were several groups of people who seemed to have
more negative psychosocial outcomes in the studies. The first group that had negative
psychosocial effects form the donation experience had knowledge that the graft they had donated
was no longer functioning in the recipient (Butt et al., 2017; Meyer et al., 2016). The other group
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that tended to have a more negative QoL following donation were those that had pre-existing
deficits in psychosocial functioning (Hsieh et al., 2017; Rodrigue et al., 2017; Timmerman et al.,
2016). Several studies tried to identify predictors to determine which living donors were most at
risk of having negative psychosocial outcomes.
Predictors of Psychosocial Responses Following Donation
The psychosocial factors identified in the studies synthesized for this literature review
were associated with either positive or negative effects on the organ donation outcomes
experienced by the living donor. There were no uniform predictors of psychosocial response to
organ donation that could be identified. In several studies gender was predictive of QoL
measures of psychosocial outcome, such as fatigue (Dew et al., 2016; Hsieh et al., 2017; Meyer
et al., 2016; Meyer et al., 2017). Another predictor that was identified in some studies was age.
Being older at the time of organ donation was considered protective and older individuals
responded more favorable on QoL measures of psychosocial outcomes (Jowsey et al., 2014;
Rodrigue et al, 2017). The existence of pre-existing mood or mental disorder was found to be a
negative indicator of psychosocial outcome in living donors (Holscher et al., 2018; Rodrigue et
al., 2017). The death of the recipient was also a negative indicator to the living donors transplant
experience (Butt et al., 2017; Jacobs et al., 2015; Rodrigue et al., 2017).
Barriers to Care of Living Organ Donors
Most of the studies suggested living donors should be monitored to ensure the donors did
not experience any negative psychosocial effects from the transplantation process. One barrier to
this involved the way the clinician would measure any changes. While the SF-36 was used in
many of the studies, there were a variety of questionnaires employed in the studies included in
this review. Without uniformity in the process of data collection, it is difficult to draw over-
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arching conclusions and assumptions to identify psychosocial complications experienced by
living organ donors and those in need of interventions following donation of an organ.
One other variable to address is when the evaluations for psychosocial complications
should take place following organ donation. There were a wide variety of time points that were
used to evaluate the psychosocial well-being of the living donors. Some studies looked at longterm effects of living organ donation by looking at living donor responses to questionnaires a
decade or more from the time the procedure occurred (Jacobs et al., 2015; Ladner et al., 2015;
Meyer et al., 2016; Noma et al., 2011). Other studies followed living donors for a much shorter
time following the transplantation procedure. These studies might have followed the living
donors for two or less years (Butt et al., 2017; Dew et al., 2018). Given that a living donor’s
experiences are not likely to be the same at different time periods following the transplantation
procedure, it is hard to compare studies that encompass such disparate time frames and apply the
authors’ findings to the living donor population in general.
Financial barriers can also present a problem for living donors. There can be large sums
of out-of-pocket expenses. Living donors can also experience problems obtaining health
insurance and life insurance following the procedure. Without gaining an understanding of the
financial implications of living organ donation, it will be impossible to develop ways to contain
the cost and prevent undue financial harm to the living donor.
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Limitations
The studies included in this literature review had several limitations. Using general
keyword searches, such as organ transplant, living donor, psychosocial, and physiologic,
provided numerous articles. When filtering for publication dates and language, the number of
articles germane to the topic greatly diminished. Only one article was identified that completely
met the inclusion criteria while looking at physiological data and QoL measures. The search was
expanded by varying the keywords and expanding the search terms to include different
permutations of the keywords like organ transplant*. The articles included in this review were
analyzed after appearing in the keyword search to determine whether they met the inclusion
criteria. This process is subjective, so some articles may have been overlooked while some may
have been erroneously included.
One of the limitations that became apparent from the studies included in this literature
review was the sample sizes of the studies. Several of the studies had sample sizes smaller than
50 individuals (Hsieh et al., 2017; Noma et al., 2011; Trotter et al., 2001; Walter et al., 2003;
Walter et al., 2002). The sample sizes of these studies make it unlikely that the living donor
population is diverse enough to apply the findings on the population at large. The largest studies
were multicenter studies that had 2,455 participants (Jacobs et al., 2015; Jowsey, 2014). Not all
the studies were made up of diverse populations. Several were conducted at single centers in
Asian or European countries (Hsieh et al., 2017; Kimura et al., 2015; Maglakelidze et al., 2011;
Meyer et al., 2017; Meyer et al. 2016; Noma et al., 2011; Walter et al., 2003; Walter et al.,
2002). All the studies were a cohort design but given the nature of the question being researched
that would be expected.

28

Retention and attrition rates in longitudinal, cohort studies can influence causal
correlations that occur in a population. Large attrition rates or low retention rates can skew the
results obtained. Even in the larger trials the response rate is important to note. Only 2,455 living
donors participated in the study out of 6,909 who had been contacted after they were found to be
eligible (a 36% response rate) (Jowsey et al., 2014). The people who ended up participating may
not be representative of the general population. Rodrigue et al. (2017) reported an 84% response
rate. The longer the study is designed to continue collecting data, the more likely the attrition rate
will grow. Rodrigue et al. (2017) lost one living donor to follow-up because the donor died.
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Recommendations for Living Donor Psychosocial Health
Future Investigations
There was one article identified that discusses an ongoing cohort study that seeks to also
answer whether the physical function of the LKD’s body is correlated to any psychosocial
outcomes. The study aims to see if kidney function is associated with changes in QoL
(Suwelack, Wörmann, Berger, Gerß, Wolters, Vitinius, Burgmer, & the German SoLKiD
consortium, 2018). The primary outcome will be the association of the eGFR with the QoL
obtained through the SF-36 in LKDs (Suwelack et al., 2018). The results from this study will add
to the body of literature that meets the inclusion criteria that was set out for this literature review.
Further studies using the similar time frames and similar questionnaires are necessary to
determine whether the psychosocial alteration observed post-donation are applicable across the
living donor population. It is hard to compare a study carried out 10 years post-donation to one
that looks at the living donor’s psychosocial outcome one year following donation. Several of the
studies used several different questionnaires (Holscher et al., 2018; Maglakelidze et al., 2011;
Maple et al., 2017). While one questionnaire might not be able to measure every aspect of the
domains of the psychosocial outcomes, it can be hard to directly compare the data obtained from
two different questionnaires.
Interventions
The predictors identified from studies are an important step in being able to identify
where interventions can be strategically employed to improve the living donor’s experience
following organ donation. These predictors allow the clinician to target those more likely to need
the intervention. Given the multifaceted dimensions related to psychosocial health, it is likely
that a variety of interventions will have to be developed.
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Since there are not many examples of interventions to address psychosocial functioning
in living donors, ideas can be generated from other conditions. Dew, Zuckoff, DiMartini, Dabbs,
McMulty, Fox, Switzer, Humar, & Tan (2012) published a report were they had developed an
intervention and did some feasibility testing to try to prevent negative psychosocial outcomes in
living donors. The framework the authors used was based upon interventions for motivational
interviews (MI’s). The goal was to motivate the living donor to change behavior thus improving
their psychosocial outcome (Dew et al., 2012). While there was no data obtained that directly
indicated the intervention improved psychosocial outcomes, the authors found that the living
donors liked being able to talk and have their comments listened to so that any concerns could be
addressed (Dew et al., 2012). Interventions based upon those used in other conditions might be a
place to begin since there are a dearth of validated examples.
Another intervention, internet-based cognitive-behavioral therapy (ICBT), was proposed
and tested for its feasibility (Wirken, van Middendorp, Hooghof, Bremer, Hopman, van der Pant,
Hoitsma, Hillbrands, & Eveers, 2018). The authors developed an ICBT intervention for LKDs
and donor candidates (Wirken et al., 2018). Anxiety and depression were assessed before and
after the intervention. Wirken et al. (2018) suggested that the intervention improved measures
such as depression in the eight living and candidate donors in the pilot study. The study was not
designed to assess effectiveness so whether the intervention works in practice remains to be seen.
Nursing Practice
The findings synthesized in this review can have various implications to the practice of
nursing. Nurses need to stay abreast of the research to practice effectively. This review
condenses what is known about the psychosocial effects of donation on living organ donors. To
be able to make sound clinical judgements, nurses need to know where holes in the current body
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of knowledge are so that decisions can be based on the evidence. Nurses are also an advocate for
their patients. Ultimately, nurses want to prevent harm to their patient by advocating on their
behalf.
Psychosocial domains are multifaceted so will require a team approach to identify and
address. Nurses are at the best position to help coordinate care to maximize the person’s
psychosocial outcome. Nurses are frequently the first to see that there is a problem due to the
amount of time that they spend with their patients. Nurses may be involved in the
implementation of interventions to resolve any psychosocial problems that living donors have.
Conclusions
While most living organ donors have no problems following donation and report no
negative psychosocial outcomes, there is a subset of living donors that do not have a pleasant
experience following donation. The nurse may be involved in identifying living donors at most
risk of having negative psychosocial outcomes through screeners or participating in a team to
implement interventions to address any problems. The literature indicates that one of the leading
factors associated with an adverse psychosocial outcome is related to the death of the recipient
(Butt et al., 2017; Jacobs et al., 2015; Rodrigue et al., 2017). When the recipient dies following
graft failure, this should be an indicator to follow the living donor more closely and implement
any necessary interventions to lessen any negative psychosocial impact. Developing
interventions to address changes in psychosocial functioning is vitally important. The examples
found so far are feasibility studies, which while they are a necessary first step. These studies not
sufficient to address the problem. Effectively identifying which patients are at risk for
developing negative psychosocial outcomes is the most important action we have at this time.
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Relevant citations obtained after screening of databases
(ERIC, CINAHL, PsycINFO, MEDLINE)
(n=258)

Citations that do not meet
inclusion criteria
(n=201)
Studies reviewed following retrieval for
inclusion
(n=57)

Studies excluded following retrieval and
review for not meeting inclusion criteria
(n=56)

Studies that met the inclusion criteria
(n=1)

Additional studies included following hand searching employing additional keywords
and credible reference citations
(total n=21)

Key Search Terms= organ transplant* AND living donor* AND psychosoc*
Limiters= English language, peer-reviewed, published between 2008-2018

Figure 1: Method for Literature Review Selection
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Table 1. Table of Evidence
Author(s)
Year
Location
Butt et al.
(2017)
United States

Study Design
and Purpose

Sample
Size

Intervention
Protocol

Screening
Measures

Outcome
Measures

Key Findings and Limitations

Cohort study

n=278

Major
depression,
anxiety, and
alcohol abuse
modules of the
Primary Care
Evaluation of
Mental
Disorders
(PRIME-MD)
were used to
assess the
LLD. Also,
the
Posttraumatic
Growth
InventoryShort Form
(PTGI-SF)
SF-36 were
employed to
measure
health related
quality of life
(HRQoL).

The average
age at donation
was 36.79 years
old. 63.1%
were either
married or in a
long-term
relationship.
Most
participants
were white with
80.4%
identifying as
non-Hispanic
white. Donors
who were not
proficient in
English were
excluded from
the study. The
better person
scale and the
PTGI-SF were
used to screen
the
psychological
characteristics.
The PRIMEMD was used

Most LLD scored
at the midpoint on
the better person
scale and the
PTGI-SF. The
factors associated
with affecting the
better person
score were time
since donation (p
< 0.001), firstdegree relative
versus being
unrelated
(p=0.012), female
gender (p=0.008),
recipient death (p
< 0.001), and
ambivalence
(p=0.005) and
motivation to
donate (p< 0.001).

The rate of mental disorders in
LLD were: 0-3% for major
depression, 2-5% for alcohol
abuse, and 2-3% for anxiety
disorders. One of the factors
that was identified that is
associated with a negative
experience from living liver
donation is whether the
recipient dies. The death of the
recipient has a negative impact
on the donor. Up to one third of
those donors felt guilt
following the death of the
recipient and up to 22% felt
some responsibility for the
death of the recipient.

Observational
Eight U.S.
transplant
centers and
one Canadian
transplant
center in
comprise the
consortium.
The purpose
was to follow
living liver
donors (LLD)
and study to
occurrence of
psychological
outcomes
following
donation.

Interviews
were
conducted
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The PRIME-MD
responses
indicated that
about 4-9.5% of
the donors had at
least one of the

Limitations: The sample did
not have a large representation
of minorities. Also, only 245
out of the 278 people enrolled
completed the initial survey
and one post-donation survey.
At the two-year post-donation
only 183 donors were eligible.

with LLD 1
month prior to
donation and
3, 6, 12, and
24 months
following
donation.
Dew et al.
Cross(2018)
sectional
United States
The purpose
of this study
was to
elucidate the
long-term
effects liver
donation had
the donor’s
QoL.

n=424

Dew et al.
Cross(2016)
sectional
United States long-term
follow-up
study

n=517

to see if LLD
had a least one
of the
syndromes at
any time point
in the study.

During the
study,
participants
were
interviewed
over the phone
for 30-45
minutes.
Research staff
would also
retrieve
clinical data
from the
donor’s
medical
records.

The SF-36 was
used to
determine the
donor’s QoL.
The
socioeconomic,
clinical factors
from medical
records, and
donor’s
perception are
assessed.
Donors were
over 18 years
old and spoke
English to be
included in this
study.
Eligible
The study
donors had to assessed 3
speak English psychosocial
and be over 18 variable and
years of age.
general
All the donors HRQoL. The
included were assessments
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syndromes
measured at some
point during the
study.

Anxiety and
alcohol abuse
disorder (p <
0.001) were more
common in LLDs.
Also, the length of
the hospital stay
post-donation,
being female,
higher BMI, fear
of health related
effects, and outof-pocket
expenses were
associated with a
decrease in QoL.

Identification of factors
adversely effecting LLDs is an
important step forward in
ensuring that the donation
process is safe for the donors.
The researches found that
anxiety and alcohol abuse
disorder were seen with an
increased frequency in LLDs.

Several factors
were identified in
the study that led
to a lower HRQoL
which include
male gender (OR
6.23, p < 0.001)

The study found that LLD
report adverse physical and
socioeconomic effects from
donation. Those at greatest risk
are non-Hispanic white males.
Up to 31 % of donors reported

Limitations: Some of the
centers included in this study
so they have relatively small
sample sizes coming form that
site. This could make it hard to
see differences in those centers.

9 transplant
centers in the
US and
Canada are
members of
the
consortium

DuBay et al.
(2009)
Canada

Crosssectional
study

n=143

3-10 years
post-donation
of their liver.
Donors were
interviewed
for 30 to 45
minutes
between 2002
and 2009.

included the
Checklist of
DonationRelated
Physical
Symptoms, the
Posttraumatic
Growth
Inventory, the
better person
scale, and the
SF-36 version
2.

The LLD in
this study
completed a
questionnaire
3 months after
donation. The
questionnaire
collected
demographic
data, HRQoL
following
donation, and
feelings about
the overall
donation
process. To
measure the
HRQoL the

The
participants in
this study came
from one
transplant
center in
Toronto,
Canada. The
participants had
donated their
livers between
April 2000 and
March 2007.
The donors
who were at
least 3 months
post-donation
received the
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and being nonHispanic white
(OR 6.35, p <
0.001). Age 40 to
50 years old (OR
0.26, p=0.008)
were more likely
to have favorable
psychological
benefit and lower
physical and
economic
concerns
following
donation.
The results from
the SF-36 were
higher than when
compared to the
average Canadian.
The physical
composite score
for the LLD was
56.4 versus 50.5
(p < 0.001).
However, the
mental composite
score was not
statistically
different than the
average Canadian
score. Physical
functioning (p <

having physical or financial
concerns following donation.
Limitations: The study is crosssectional, which prevents
comparing pre- and postdonation status. The study was
conducted in adults so whether
the findings correlate to the
pediatric population experience
is impossible to infer.

In the SF-36v1 the LLDs
scored better than the average
Canadian on the physical
domains, but no predictors of
HRQoL post-donation could be
determined. On the other hand,
there were several predictors
that could be identified for the
mental HRQoL post-donation.
Age (p=0.023), presence of a
psychiatric diagnosis
(p=0.007), degree attained
(p=0.001), and pre-donation
concerns about donation all
(p=0.029) were all predictors of
mental health changes seen
following liver donation.

Holscher et
Cohort study
n=825
al.
(2018)
Ongoing
United States study of living
kidney
donors.

authors used
the SF-36v1.

questionnaire
by mail. More
Females than
males
completed the
questionnaire
(52% versus
33%).

0.001), role
interference (p <
0.05), bodily pain
(p < 0.001),
general health (p <
0.001), and
vitality (p < 0.05)
were all domains
that the LLDs
scored better than
the average
Canadian on.

Living kidney
donors (LKD)
were sent
quality of life
surveys and a
survey
detailing
medical,
surgical,
hospitalization
, psychiatric,
and social
history.

Participants has
a nephrectomy
between 1982
and 2015.
Enrollment
started in 2011.
The GAD-2
anxiety screen,
PHQ-2
depression
screen, and the
5-point Likert
scale were
employed to
measure the

Outcomes that
were measure
included a score
of 3 or higher on
the GAD-2
anxiety screen, a
score of 3 or
higher on the
PHQ-2 depression
screen, and the 5point Likert scale.
A positive screen
for depression was
more likely if the
person also
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Limitations: The response rate
for this study was 70%, so a
large portion of eligible
participants were either lost to
follow-up or chose not to
participate. This can affect the
study’s validity because the
population might not be
representative of all the people
that undergo this procedure.
The study did not give the
questionnaires to the
participants at set timepoints.
The LLDs feelings of the
experience could change over
time so comparing different
donors at different time points
my change the effect seen.
Overall the incidence of
anxiety, depression, and
regretting the decision to
donate their liver occurred in
5.5%, 4.2%, and 2.1% of the
respondents. These conditions
were very inter-related and a
positive screen for one was
often correlated with a positive
screen for another.
Limitations: Unlike other
studies, this study was
conducted at one transplant
center, which limits the

psychosocial
domains.

Hsieh et al.
(2017)
Taiwan

Crosssectional
study
The purpose
of the study is
to determine
the factors
that have a
positive and
negative
affect along
with the
HRQoL in
LKD.

n=41

The physical
health of the
LKD was
assessed along
with
demographic
data. The
Medical
Outcomes
Study 12-Item
Short-Form
Health Survey
measured
physical
HRQoL
through the
physical

screened positive
for anxiety (p <
0.001). A positive
depression screen
was also more
likely to occur
when the recipient
experienced graft
loss (p < 0.001).
In addition, regret
was more likely to
be seen when the
person had a
positive anxiety
screen (p
<0.0001).
The
Patients were
participants had measured for
the
positive and
nephrectomy
negative affect
more than 3
and HRQoL.
months before
Factors associated
participating in with positive
the study. All
affect were
participants had gender, chronic
to be able to
disease, and
communicate in perceived physical
Chinese or
health. Factors
Taiwanese.
associated with
Creatinine
negative affect are
clearance,
relationship to
serum
recipient, chronic
creatinine, codisease, and
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potential pool or participants.
The study may not have
enough participants to truly be
able to see differences between
the outcomes and donor
characteristics.

When the LKD had a higher
positive affect, their HRQoL
scores were generally higher (p
< 0.05). Employment led to
higher mental HRQoL (p <
0.05). When LKD had a lower
negative affect score, their
mental HRQoL was higher (p <
0.01). Men, donors who are
siblings of the recipient, donors
having chronic disease, and
having poor physical health
were more likely to have a
decreased HRQoL.
Limitations: This study was
small and consisted of

Jacobs et al. Cohort study
(2015)
United States Aim was to
determine the
characteristics
that are
associated
with poor
psychosocial
outcomes in
LKD.

n=2455

component
survey and the
mental
component
survey.

morbid
diseases, as
well of
demographic
data, such as
marriage status,
educational
level, and
religious
affiliation were
gathered along
with measuring
physical and
mental HRQoL.

Questionnaire
s were mailed
to 6909
kidney donors
from three
transplant
centers in the
US. 2455
responded to
the 11-page
questionnaire.

The
questionnaire
encompassed
areas such as
psychosocial,
financial, and
donor
outcomes. Data
was collected
between 2010
to 2012 with
LKD that
donated from
June 1963 to
June 2005. The
mean time
41

perceived physical
health. Women
demonstrated a
higher positive
affect than men (p
< 0.05). Lack of a
chronic disease
was associated
with a positive
affect (p < 0.05).
If the person
perceived having
higher physical
health, the
positive affect
score was higher
(p < 0.01).
In regard to
psychosocial
outcomes, the
authors looked at
overall donation
experience;
financial burden
due to donation;
whether the donor
would donate
again; emotional,
psychological, or
substance abuse;
or regrets with
donating their
kidney. The only

exclusively Asian participants,
which limits wider application
of its findings.

A total of 231 patients reported
that they experienced a
negative psychosocial outcome
following donation. Almost 1
in 10 donors experienced a
negative consequence related to
their decision to donate their
kidney. One in 5 donors ended
up taking unpaid leave and up
to 2% reported having concerns
with life and health insurance,
which contributes to the
financial burden of donation.

Jowsey et al. Cross(2014)
sectional
United States cohort study
The purpose
of this study
was to reveal
the long-term
effects of
LKD on the
donor. The
study was
designed to
see
differences in
depression in
kidney
donors.

n=2455

since donation
was 17 years
(ranged from 5
to 48 years).
Respondents
were highly
educated (21%
had a 4-year
college degree)
and were white
(93%).
Researchers
Donors who
gathered data
were targeted in
from LKD
this study
records. This
donated their
occurred prior kidneys
to the study.
between 1963
The donors
and 2005 at one
were then
of 3 transplant
invited to join centers. Areas
the study. The queried in the
participants
questionnaire
completed a
were: loss of
short
interest,
questionnaire depressed
initially and
mood, sleep,
then were
appetite and
given more in- energy changes,
depth
alterations in
questionnaires self-worth,
on their
concentrating
medical and
problems,
alterations in
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predictor that was
associated with
poor psychosocial
outcome was that
the recipient’s
kidney was no
longer functioning
(OR 1.77, CI
1.33-2.34, p <
0.001).

Limitations: While this study
had a larger sample size, the
response rate was only 36%.

The study utilized
the Patient Health
Questionnaire
(PHQ-9)
Depression Scale,
the Life
Orientation TestRevised (LOT-R),
and the 36-Item
Short Form Health
Survey (SF-36)
for measuring
QoL. The PHQ-9
indicated that
fewer depressive
symptoms were
associated in LKD
who reported
better physical
health (p < 0.001),
older when
underwent

For the most part LKD do not
experience an increase in
depressive symptoms. The
minority that do experience
depressive symptoms have a
history of depression that
predates kidney donation.
Longer recovery (p=0.009),
financial stressors (p=0.013),
younger (p=0.002), obligation
to donate (p=0.003), and
recipient graft status (p=0.007)
are associated with a LKD
more likely to develop
depression.
Limitations: While the study
included patients from three
transplant centers, there was
less representation of ethnic
minorities than represented in
the US population.

Kimura et al.
(2015)
Japan

Cohort study
The purpose
of this study
was to
demonstrate
whether there
was a
correlation
between
physiological
variables and
the LLDs
quality of life.

n=142

psychosocial
status.

their
psychomotor
activities, and
suicidal
ideations.

The potential
donors were
evaluated by a
teen of
psychiatrists
and
psychologists
to determine
their intent
and to
determine
whether they
understood the
risks
associated
with donating
their liver. The
potential
donors were
evaluated for
mental illness
using a
structured
interview for
the Diagnostic

The donors
identified in
this study were
selected
between April
2004 and July
2005. The
subjects
included in this
study did not
have a mental
disorder prior
to donating
their liver.
Screening was
performed and
measured by
the donor’s
performance on
the SCID. The
donors with
mental health
disorders were
monitored on
the Global
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donation
(p=0.002), a
higher score on
the LOT-R (p
<0.001), being
employed (p <
0.001), and being
white (p=0.002)
Six (4.2%) of the
142 LLDs
included in this
study developed a
mental health
disorder. The
donors who
developed mental
health disorders
had complications
post-transplant
including inferior
vena cava
thrombosis,
wound infection,
severe anemia,
and bile leakage.
All the donors
who had mental
health disorders
showed an
improvement on
their GAF scale
scores. With
therapy 3

This study was very small in
scale. Essentially only 6 LLDs
were identified as having a
mental health disorder out of
the 142 screened. In half the
LLDs that developed a mental
disorder therapy was required
over an extended period of
time. The exact cause of the
mental disorders is not entirely
clear. It could be due many
factors including relationship
problems with the recipient,
death of the recipient following
transplant, and environmental
and genetic factors.
Limitations: The sample size in
this study is small. Only 6
people out of the 142 total LLD
identified as having a mental
health disorder and followed
through the course of their
mental illness. This study was
also conducted at one

Ladner et al. Cohort study
n=374
(2015)
United States The goal for
this study is to
characterize
the HRQoL
for LLD up to
11 years
following
donation.

and Statistical
Manual of
Mental
Disorders,
Fourth
Edition, Test
Revision
(DSM-IV-TR)
(SCID).
The study was
conducted
using data
from 9
transplant
centers. The
LLD were
evaluated
before the
procedure and
at 3 months,
one year, and
then yearly up
to 8 years
post-donation.

Assessment of
Functioning
Scale (GAF).

achieved
remission while 3
continued
treatment.

transplant center in Japan, so
whether the results would hold
up nation-wide or in other
countries has not been
addressed.

Between 2004
and 2013, LLD
were evaluated
with the Short
Form survey
(SF-36) for
LLD who had
donated
between 1998
and 2010. The
researchers
looked at the
physical and
mental
component
summaries
(PCS and MCS,
respectively).

The SF-36
consists of 36
questions that
provides data to
compute the PCS
and MCS scores.
The average age at
donation was 38
and 93% of the
donors were
white. 43% of the
donors had a
bachelor’s degree
or higher. The
largest predictor
of a poor PCS or
MCS score was
the death of the
recipient within 2
years of
transplantation
(PCS p=0.046;
MCS p=0.0004).

While most LLD maintain their
HRQoL post donation, there
are a subset of LLD that are not
able to maintain these levels
and develop a poor HRQoL.
Educational level is a
protective factor in those with a
bachelor’s degree or higher
generally reporting a higher
PCS score (p=0.023).
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Limitations: This study was
generated from several
transplant centers; however,
93% of the participants were
white, which does not reflect
the general US population.

Maglakelidze Prospective
n=57
et al.
cohort study
(2011)
Georgia
The purpose
of the study
was to
determine if
HRQoL was
different than
a sample of
healthy
matched
people and a
small sample
of patients
who had
nephrectomies
following
renal tumors.

The
participants in
this study
received three
questionnaires
, the SF-36,
Giessen
Subjective
Complaints
List (GBB24), and
Zerssen’s
Mood Scale
(Bf-S).

The mean age
of the LKD
included in the
study was 49
years old.
There had been
61 kidney
transplants
since 2005 and
57 of the
donors
responded to
the
questionnaires.
This gives a
93% response
rate. The study
uses the
commonly used
SF-36 to
measure the
HRQoL for
LKD. The
authors
compare LKD
to patients who
had
nephrectomies
due to renal
tumors. This is
a novel
approach and
allows them to
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The SF-36 found
three domains
where the LKD
were seen to
function
statistically
superior to the
control groups.
Social functioning
(p=0.0001), bodily
pain (p=0.0357),
and vitality
(p=0.0478) were
three domains that
the LKD scored
higher than the
control group. In
the GBB-24, the
LKD group scored
higher than the
other groups but
only the gastric
complaints were
significantly better
(p=0.008) better
than the control’s
scores. The mood
of the LKD were
also significantly
better than the
controls
(p=0.0007).

This study found that the
HRQoL was generally better
for LKD. There were not any
dimensions that the authors
mentioned where either the
controls or renal tumor patients
out-scored the LKD.
Limitations: The sample size is
small and relatively
homogenous given the
countries size. It would be hard
to extrapolate these findings
due to these limitations.

Maple et al.
(2017)
United
Kingdom

Prospective
longitudinal
study
The authors of
this study
wanted to
quantify the
psychosocial
effects of
donation on
LKD.

n=77

compare LKD
to others who
have one
functional
kidney.
LKD were
The LKD were
recruited for
selected for this
this study in
study between
their last
August 2010 to
preoperative
August 2013.
visit before
Responses were
donating their obtained before
kidney. The
donation and at
questionnaire 3- and 12consisted of
months
two parts. The following
first part
donation. The
consisted of
psychosocial
11 validated
factors
measures of
measured were
psychosocial
wellbeing,
outcomes. The distress, mood,
second part
stress, physical
asked
HRQoL, life
questions
satisfaction,
related to
self-esteem,
transanxiety, social
plantation.
support,
optimism, and
social
comparison.
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At 3 months, LKD
scored lower on
physical HRQoL
(p < 0.05)
compared to their
pre-operative
scores. While
there was a
general increase in
the scores for
depression,
depression scores
were not
significantly
different than preoperative scores.
From this LKD
population, 6.8%
regretted their
decision to donate
at 3-months, and
10.7% regretted
their decision at
12-months.

Overall, there was very little
change in the overall
psychosocial health of LKD in
this study. The second part of
the study reflected the feelings
LKD had regarding the
process. Most LKD had
positive feelings about
donating their kidneys. The
authors purported no benefit
from kidney donation for the
living donor, but there was not
a negative effect either.
Limitations: This study had a
relatively small sample size.
Given that questions were
added that were not part of
validated questionnaires, the
changes seen over time might
not have been great enough to
detect.

Meyer et al.
(2017)
Norway

Prospective
follow-up
cohort study

n=202

The purpose
of this study
was to
demonstrate
whether
kidney
donation was
associated
with longterm physical
complications
or a reduction
in HRQoL in
living donors.

Meyer et al.
(2016)
Norway

Crosssectional
cohort study
The purpose
of this study
was to follow
a cohort of
kidney donors
over 8-12

n=217

This study
involved
obtaining
clinical values
such as blood
pressure,
serum
creatinine,
hemoglobin,
and estimated
glomerular
filtration rate
(eGFR). The
SF-36v2 was
employed to
assess changes
to HRQoL 10
years after
organ
donation.

Those included
in this study
underwent
donation
between 2001
and 2004.
Clinical data
obtained for
this study
included: blood
pressure, BMI,
creatinine,
eGFR,
hemoglobin,
PTH,
cholesterol,
triglycerides,
HDL and LDL.
Scores from the
PCS and MCS
were obtained
from the SF36v2.
The authors of The members
this study
of tis cohort
employed the donated their
SF-36 v2,the
kidneys
Multidimensio between 2001
nal Fatigue
and 2004. To
Inventory
measure
(MFI), and
HRQoL PCS,
donor specific MCS, physical
questions,
functioning,
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There was no
statistically
significant
association
between the
clinical variables
and either the PCS
or MCS. The only
statistically
significant
correlations were
seen between
gender and
general fatigue (p
< 0.05) and
between BMI and
physical fatigue (p
< 0.01).

This was one of the initial
studies that looked to see if
there was a correlation with the
donors physiological state with
the psychosocial outcomes a
decade after donation.
Hypertension may be more
prevalent in the LKD group,
but it does not achieve
statistical significance.
Limitations: The study may not
have been powered to detect
differences due to the size of
the effects measured and the
population included in the
study. The study also took
place in Norway, which is not
as diverse as other places such
as the US, so the authors’
conclusions might not have
generalizability.

Most of the
HRQoL domains
did not
demonstrate a
difference in score
related to age of
gender. The
exceptions were
that females score
significantly lower

Most LKD participants in the
study rated the HRQoL
favorably. The most important
implication of this study was
the gender differences seen in
the responses to the MFI
questionnaire. This study
demonstrated that women rated
their fatigue higher than men
within the cohort. This result is

years and see
if there was
any change in
HRQoL in
this cohort.

Noma et al.
(2011)
Japan

Prospective
cohort study
The authors
observed the
psychosocial
states of
living liver
donors and
recipients.
The goal was
to see if there

which also
addressed
clinical
outcomes.

n=30

The StateTrait Anxiety
Inventory
(STAI) and
Beck
Depression
Inventory
(BDI) were
used to assess
the
participants’
mental health

role physical,
vitality, mental
health, role
emotional,
social
functioning,
general health,
and body pain
were scored.
The MFI
measured
fatigue with
domains such
as general
fatigue,
physical
fatigue, mental
fatigue, reduced
motivation, and
reduced
activity.
Anxiety,
Depression, and
perceived
quality of life
were measure
through the
questionnaires
were measured
several years
after
transplantation.
Long-term
48

on their role
physical and role
emotional scores.
In relation to the
fatigue score, once
again gender was
not associated
with any
difference in
scored responses.
When looking at
gender, women
score higher on
general fatigue
(p=0.01), physical
fatigue (p=0.01),
reduced
motivation
(p=0.04), and
mental fatigue
(p=0.03).
In this study both
recipients and
donors were
followed after
liver transplant.
The donors
reported less
anxiety symptoms
using the STAI-S
following
transplant
(p=0.027). The

not consistent with results seen
in other studies. Further studies
are necessary to see whether
this result is significant.
Limitations: This study was
conducted at one center in
Norway. Also, the population
is less diverse in this country
than in other such as the US.
The findings may not be
applicable to the across all
countries and ethnicities due to
the homogeneity of the
Norwegian population.

The main predictors of the
donor’s psychosocial state
following liver transplant were
family or support system
availability and the recipients’
depressive states when the liver
transplant is performed. The
social QoL was affected in both
donors and recipients 3 to 5
years following liver donation.

were
characteristics
that would
predict postdonation
response to
psychosocial
domains.

Rodrigue et
Observational
al.
cohort study
(2017)
United States The purpose
of this study
was to build
upon previous
studies which
explored the
financial
burden of
living kidney
donation. In
this study the
authors
wanted to
explore the
effect of
donation on
the
psychosocial

n=193

while the
World
Organization
Quality-ofLife
Assessment26
(WHOQOL26) was used
to assess
psychosocial
domains.
The authors
utilized the
Profile of
Mood States
(POMS) to
assess anxiety,
depression,
and anger. To
assess the fear
of kidney
rejection the
authors used
the 5-item
Fear of
Kidney
Failure (FKF)
questionnaire.
To assess
body image,
the 10-item
body image

outcomes in
liver transplant
were explored
by looking at
the effects of
several
variables on
both recipients
and donors.

social QoL
(p=0.026) and
total QoL
(p=0.005) also
diminished
following
donation.

Limitations: This study only
included 30 donors and 40
recipients. This study is also
conducted exclusively in Japan
and the results might not be
applicable in other countries or
in other races.

LKD were
recruited from
6 transplant
centers in the
US from
September
2011 to
November
2013. All
participants
were older than
18 when
enrolled and
spoke English
or Spanish. For
assessing mood
and body image
higher scores
reflected more
mood
disturbance or

Overall, The
scores obtained
showed that both
LKDs and HCs
scored similarly
on most of the
HRQoL measures.
Older age is
associated with a
lower mood
disturbance score
(p=0.001) and predonation mood
disturbances are
associated with a
higher mood
disturbance score
(p=0.01). Fear of
kidney failure is
associated with
pre-donation

For the most part, the incidence
of new onset mood
disturbances, body image
issues, life dissatisfaction, and
fear of kidney failure were low
in this study. The reported
incidences were 16%, 13%,
10%, and 21%, respectively.
These values are in agreement
with what other researchers had
published, but further studies
are necessary to ensure that
there really is a difference
between LKDs and HCs.
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Limitations: Only 20 HCs were
included in the analysis of this
study. That is not a large
enough number to truly
compare the two groups. The
sample size is moderate in size

domains:
mood, fear of
kidney failure,
body image, ,
life
satisfaction,
and decisional
stability.

Timmerman
et al.
(2016)
Netherlands

Prospective
cohort study
The purpose
of this study

n=151

scale (BIS)
was
employed.
The 5-item
Satisfaction
with Life
Scale (SWLS)
was employed
to measure life
satisfaction. A
series of
questions were
employed to
assess
decisional
stability. The
questionnaires
were
conducted at
1, 6, 12, and
24 months.

poorer body
image. A
higher score in
life satisfaction
indicated
increased life
satisfaction.

The
participants
took part in a
structured
interview and

Participants
were recruited
between July
2011 and
September
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kidney failure (p <
0.001) and
associated with a
lower score for
married
individuals
(p=0.004). Body
image concerns
were associated
with higher scores
for pre-donation
body image
concerns
(p=0.002) and
perceived
donation pressure
(p=0.02). Being
white was
associated with a
lower life
dissatisfaction
score (p=0.003)
while predonation life
dissatisfaction was
associated with a
higher score (p <
0.001).
Mental health was
measured by the
Brief Summary
Intervention (BSI)
and the Positive

and unlikely to truly reflect the
population as a whole.

Being young and a deficiency
in social support were
associated with an increase in
psychological symptoms
(p=0.002 and p=0.001,

is to
determine
whether stress
mediates the
psychosocial
effects
following
LKD.

Timmerman
et al.
(2015)
Netherlands

Cohort study

n=135

The purpose
of the study is
to further
elucidate the
effect living
kidney
donation has
on mental
health.

Trotter et al. Cohort study
(2001)
United States The authors
wanted to

n=24

a
questionnaire
prior to
donation and
at 3 and 12
months.

2012. LKDs
had to be at
least 18 years
old and speak
Dutch.

The authors
got
demographic
data and
measured QoL
with the BSI
and MHC-SF.
The primary
analysis was
conducted at
pre-donation
and at 6
months.
The authors
used the
Medical
Outcomes

LKDs were
recruited
between July
2011 and
September
2012.

In August of
2000, the 24
LLD that
signed
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and Negative
Affect Schedule
(PANAS). Wellbeing was
measured by the
Dutch Mental
Health
Continuum-Short
Form (MHC-SF).
Stress was
measured through
the Depression
Anxiety Stress
Scale. Coping
scored using the
COPE-Easy.
Mental health was
assessed utilizing
the BSI and
MHC-SF. There
was no change in
psychological
disorders (p=0.2)
or well-being
(p=0.1).

respectively). More stress led
to a decrease in overall wellbeing (p <0.001).

LLD scored
similarly to the
HCs in all
domains of the

Major and minor complications
occurred in 16% of the donors.
Most LLD made a complete
recovery; however, it took

Limitations: Some of the scales
used to quantify the
questionnaires have not had
their validity confirmed in the
situation. The sample size is
relatively small which can
affect the ability to see changes
in outcomes.

The analysis of the study fails
to provide evidence that the
HRQoL is affected by any of
the factors identified in this
study.
Limitations: The patients in the
LKD group are more likely to
be older, which may not reflect
the normal age distribution.

determine the
effect of
psychosocial
domains on
LLD.

Walter et al.
(2003)
Germany

Cohort study
The purpose
of this study
was to see if
one could
correlate the
donor’s QoL
with
complications
that occur.

Study 36-Item
Short Form
Survey (SF36) to assess
the
psychosocial
domains of the
donors.

n=28

In this study
the authors
subjected the
LLD to
interviews and
performed
psychological
tests. The
authors used
the WHOQOL
questionnaire
to determine
any
differences in
QoL.

informed
consent were
sent the SF-36
questionnaire.
The LLDs
mean age was
33.2 years old.
Men also made
up 58% of the
cohort.

The LLDs were
recruited
between
August 2000 to
January 2002.
The average
age of the LLD
was 41 years
old. The
domains
included in the
WHOQOL
questionnaire
are: physical
health,
psychological
state, social
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SF-36 except for
physical function,
social function,
and mental health
(p < 0.05) where
the LLDs scores
were higher than
the controls.

approximately 3.4 months to
achieve. Even though the
procedure was not painless and
there was a significant out-ofpocket expense associated with
donating their liver, all donors
answered that they would
donate again.

Limitations: This study has a
small sample size and the racial
make-up of the study does not
reflect the racial make-up of
the US population. 71% of the
participants were white in this
study.
Before donating
In general, most of the LLDs
their liver,
reported that their QoL as
members of the
good. This study served as an
cohort scored
early example on which others
significantly better have expanded our
than the controls
understanding of the HRQoL.
in all domains
The majority of donors in this
measured with the study were not affected by the
WHOQOL
procedure; however, to really
questionnaire (p < determine whether there is an
0.05). Once the
effect there needs to be a larger
donors made it to sample size.
the 6-month mark,
they scored lower Limitations: This study is small
on physical health and was included to provide
(p < 0.05) and
some historical context.

Walter et al.
(2002)
Germany

Pilot study
The goal of
the study was
to correlate
psychosocial
outcomes and
post-operative
complications
.

n=23

functioning,
and living
conditions.
A total of 26
LDLT we
identified at
VirchowKlinikum
during the
period of
December
1999-October
2000. The
average age
was 41 years
old (ranged
from 20-years
old to 66 years
old). Donors
were assessed
using a variety
of quality of
life (QoL)
measures.

Psychosocial
parameters
were
measured
through the
following
assessments:
the
Anamnestic
Comparative
Self
Assessment
Scale
(ACSA), the
Berlin Mood
Questionnaire;
Giessen
Complaint
Questionnaire;
and the Selfeffectiveness,
Optimism, and
Pessimism
Three donors
Questionnaire. were excluded
due to lack of
German
proficiency.
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living conditions
(p < 0.05).
Change in QoL 6
months following
transplant from
pre-transplant
levels.
Global quality of
life significantly
higher 6 months
following
donation
(p=0.044).
However,
following
donation 26% had
high values for
tiredness (p <
0.0012) and
fatigue (p <
0.0012). Other
measures of
physical
complaints were
not statistically
different from the
average
population.

Generally, LDLT donors rated
their global QoL higher
following donation of their
liver. While donors reported
increases in tiredness (p <
0.021) and fatigue (p < 0.0012)
6 months following organ
donation (p < 0.021), donors
reported less anxious
depression following donation
(p < 0.002). Post-operative
complications did not
significantly affect the QoL
domains.

Limitations: The sample size
for this study is extremely
small. Also, the donors were
usually spouses or children of
the recipients, which could
affect perception of the
experience.
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